| Dr Harold Allen Levine, DO | |
|
1200 7th Ave N, St Petersburg, FL 33705-1300 | |
| (866) 762-1743 | |
| (727) 813-1222 |
| Full Name | Dr Harold Allen Levine |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 1200 7th Ave N, St Petersburg, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184079998 | NPI | - | NPPES |
| 024657100 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | OS6810 (Florida) | Primary |
| Entity Name | Behavioral Health Management Services, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417052713 PECOS PAC ID: 1456262450 Enrollment ID: O20040115000480 |
News Archive
inVentiv Health, Inc., a leading provider of outsourced clinical development, launch and commercialization services to the global healthcare industry, today announced that it has signed a definitive agreement to acquire Campbell Alliance, a leading management consulting firm specializing in serving the pharmaceutical and biotech industries. Yesterday, inVentiv announced that it has signed a definitive agreement to purchase i3 from Ingenix.
Women who are overweight and obese can find accessing healthcare difficult and stressful, according to research in the latest UK-based Journal of Advanced Nursing.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the chronic pain drug market will experience modest four percent annual growth from 2008 to 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Although the market will increase over the next decade, generic erosion will constrain sales of key branded agents such as Johnson & Johnson's Topamax (topiramate) and Pfizer's Celebrex (celecoxib).
New Penn Medicine research shows that neuropsychiatric symptoms such as depression, anxiety and fatigue are more common in newly diagnosed Parkinson's disease (PD) patients compared to the general population.
› Verified 7 days ago
| Entity Name | Winter Haven Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477599975 PECOS PAC ID: 4789578972 Enrollment ID: O20040210000095 |
News Archive
inVentiv Health, Inc., a leading provider of outsourced clinical development, launch and commercialization services to the global healthcare industry, today announced that it has signed a definitive agreement to acquire Campbell Alliance, a leading management consulting firm specializing in serving the pharmaceutical and biotech industries. Yesterday, inVentiv announced that it has signed a definitive agreement to purchase i3 from Ingenix.
Women who are overweight and obese can find accessing healthcare difficult and stressful, according to research in the latest UK-based Journal of Advanced Nursing.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the chronic pain drug market will experience modest four percent annual growth from 2008 to 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Although the market will increase over the next decade, generic erosion will constrain sales of key branded agents such as Johnson & Johnson's Topamax (topiramate) and Pfizer's Celebrex (celecoxib).
New Penn Medicine research shows that neuropsychiatric symptoms such as depression, anxiety and fatigue are more common in newly diagnosed Parkinson's disease (PD) patients compared to the general population.
› Verified 7 days ago
| Entity Name | Baycare Behavioral Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225312549 PECOS PAC ID: 4688649122 Enrollment ID: O20040830000131 |
News Archive
inVentiv Health, Inc., a leading provider of outsourced clinical development, launch and commercialization services to the global healthcare industry, today announced that it has signed a definitive agreement to acquire Campbell Alliance, a leading management consulting firm specializing in serving the pharmaceutical and biotech industries. Yesterday, inVentiv announced that it has signed a definitive agreement to purchase i3 from Ingenix.
Women who are overweight and obese can find accessing healthcare difficult and stressful, according to research in the latest UK-based Journal of Advanced Nursing.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the chronic pain drug market will experience modest four percent annual growth from 2008 to 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Although the market will increase over the next decade, generic erosion will constrain sales of key branded agents such as Johnson & Johnson's Topamax (topiramate) and Pfizer's Celebrex (celecoxib).
New Penn Medicine research shows that neuropsychiatric symptoms such as depression, anxiety and fatigue are more common in newly diagnosed Parkinson's disease (PD) patients compared to the general population.
› Verified 7 days ago
| Entity Name | Baycare Behavioral Health Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245502152 PECOS PAC ID: 2567624836 Enrollment ID: O20120502000477 |
News Archive
inVentiv Health, Inc., a leading provider of outsourced clinical development, launch and commercialization services to the global healthcare industry, today announced that it has signed a definitive agreement to acquire Campbell Alliance, a leading management consulting firm specializing in serving the pharmaceutical and biotech industries. Yesterday, inVentiv announced that it has signed a definitive agreement to purchase i3 from Ingenix.
Women who are overweight and obese can find accessing healthcare difficult and stressful, according to research in the latest UK-based Journal of Advanced Nursing.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the chronic pain drug market will experience modest four percent annual growth from 2008 to 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Although the market will increase over the next decade, generic erosion will constrain sales of key branded agents such as Johnson & Johnson's Topamax (topiramate) and Pfizer's Celebrex (celecoxib).
New Penn Medicine research shows that neuropsychiatric symptoms such as depression, anxiety and fatigue are more common in newly diagnosed Parkinson's disease (PD) patients compared to the general population.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Harold Allen Levine, DO 2995 Drew St Fl 2, Clearwater, FL 33759-3012 Ph: (727) 315-6974 | Dr Harold Allen Levine, DO 1200 7th Ave N, St Petersburg, FL 33705-1300 Ph: (866) 762-1743 |
News Archive
inVentiv Health, Inc., a leading provider of outsourced clinical development, launch and commercialization services to the global healthcare industry, today announced that it has signed a definitive agreement to acquire Campbell Alliance, a leading management consulting firm specializing in serving the pharmaceutical and biotech industries. Yesterday, inVentiv announced that it has signed a definitive agreement to purchase i3 from Ingenix.
Women who are overweight and obese can find accessing healthcare difficult and stressful, according to research in the latest UK-based Journal of Advanced Nursing.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the chronic pain drug market will experience modest four percent annual growth from 2008 to 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Although the market will increase over the next decade, generic erosion will constrain sales of key branded agents such as Johnson & Johnson's Topamax (topiramate) and Pfizer's Celebrex (celecoxib).
New Penn Medicine research shows that neuropsychiatric symptoms such as depression, anxiety and fatigue are more common in newly diagnosed Parkinson's disease (PD) patients compared to the general population.
› Verified 7 days ago
Dr. Steven R. Cohen, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2201 Central Ave, Suite 200, St Petersburg, FL 33713 Phone: 727-824-7132 Fax: 727-824-7133 | |
Garcia Jose Desousa, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3334 66th St N, St Petersburg, FL 33710 Phone: 727-341-1333 Fax: 727-347-8675 | |
Dr. Mark Allen Cavitt, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 880 6th St S, Suite 110, St Petersburg, FL 33701 Phone: 727-767-8477 Fax: 727-767-8244 | |
Alina Gonzalez-mayo, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1201 5th Ave N, Suite 305, St Petersburg, FL 33705 Phone: 727-327-3737 Fax: 727-825-1377 | |
Rafael Alberto Beltran Durango, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3637 4th St N, Suite 480, St Petersburg, FL 33704 Phone: 727-894-2341 Fax: 727-894-2386 | |
Dr. Jeffrey Lee Alvaro, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 880 6th St S, Suite 110, St Petersburg, FL 33701 Phone: 727-767-8477 Fax: 727-767-8244 | |
Dr. Lia Nardone, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 145 5th Ave Ne, St Petersburg, FL 33701 Phone: 727-820-0505 Fax: 727-820-9707 |